Search PubMed⌕ Search

Biomedical subjects

Honglin Xu

Publications and source records attributed to Honglin Xu.

9 recordsLinked to original sources

Impaired response to Listeria in H2-M3-deficient mice reveals a nonredundant role of MHC class Ib-specific T cells in host defense.

The major histocompatibility complex (MHC) class Ib molecule H2-M3 primes the rapid expansion of CD8+ T cells by presenting N-formylated bacterial peptides. However, the significance of H2-M3-restricted T cells in host defense against bacteria is unclear. We generated H2-M3-deficient mice to investigate the role of H2-M3 in immunity against Listeria monocytogenes (LM), a model intracellular bacterial pathogen. H2-M3-deficient mice are impaired in early bacterial clearance during primary infection, with diminished LM-specific CD8+ T cell responses and compromised innate immune functions. Although H2-M3-restricted CD8+ T cells constitute a significant proportion of the anti-listerial CD8+ T cell repertoire, the kinetics and magnitude of MHC class Ia-restricted T cell responses are not altered in H2-M3-deficient mice. The fact that MHC class Ia-restricted responses cannot compensate for the H2-M3-mediated immunity suggests a nonredundant role of H2-M3 in the protective immunity against LM. Thus, the early H2-M3-restricted response temporally bridges the gap between innate and adaptive immune responses, subsequently affecting the function of both branches of the immune system.

Animals↗

A cell-type specific CD1d expression program modulates invariant NKT cell development and function.

Invariant NK T (iNKT) cells are a distinct subset of T cells that rapidly produce an array of immunoregulatory cytokines upon activation. Cytokines produced by iNKT cells subsequently transactivate other leukocytes and elicit their respective effector functions. In this way, iNKT cells play a central role in coordinating the development of immune responses in a variety of settings. However, the mechanisms governing the quality of the iNKT cell response elicited remain poorly defined. To address whether changes in the CD1d expression pattern could regulate iNKT cell function, we generated a transgenic (Tg) mouse model in which thymocytes and peripheral T cells express high levels of CD1d (Lck-CD1d Tg+ mice). The expression of CD1d by T cells was sufficient to rescue development of iNKT cells in mice deficient of endogenous CD1d. However, the relative proportions of iNKT cell subsets in Lck-CD1d Tg+ mice were distinctly different from those in wild-type mice, suggesting an altered developmental program. Additionally, iNKT cells were hyporesponsive to antigenic stimulation in vivo. Interestingly, Lck-CD1d Tg+ mice develop liver pathology in the absence of any exogenous manipulation. The results of these studies suggest that changes to the CD1d expression program modulate iNKT cell development and function.

Animals↗

Identification of a glyphosate-resistant mutant of rice 5-enolpyruvylshikimate 3-phosphate synthase using a directed evolution strategy.

5-enolpyruvylshikimate 3-phosphate synthase (EPSPS) is a key enzyme in the shikimate pathway and is targeted by the wide-spectrum herbicide glyphosate. Here, we describe the use of a selection system based on directed evolution to select glyphosate-resistant mutants of EPSPS. Using this system, the rice (Oryza sativa) EPSPS gene, mutagenized by Error-Prone polymerase chain reaction, was introduced into an EPSPS-deficient Escherichia coli strain, AB2829, and transformants were selected on minimal medium by functional complementation. Three mutants with high glyphosate resistance were identified in three independent glyphosate selection experiments. Each mutant contained a C(317)-->T transition within the EPSPS coding sequence, causing a change of proline-106 to leucine (P106L) in the protein sequence. Glyphosate resistance assays indicated a 3-fold increase in glyphosate resistance of E. coli expressing the P106L mutant. Affinity of the P106L mutant for glyphosate and phosphoenolpyruvate was decreased about 70-fold and 4.6-fold, respectively, compared to wild-type EPSPS. Analysis based on a kinetic model demonstrates that the P106L mutant has a high glyphosate resistance while retaining relatively high catalytic efficiency at low phosphoenolpyruvate concentrations. A mathematical model derived from the Michaelis-Menten equation was used to characterize the effect of expression level and selection conditions on kinetic (Ki and Km) variation of the mutants. This prediction suggests that the expression level is an important aspect of the selection system. Furthermore, glyphosate resistance of the P106L mutant was confirmed in transgenic tobacco (Nicotiana tabacum), demonstrating the potential for using the P106L mutant in transgenic crops.

3-Phosphoshikimate 1-Carboxyvinyltransferase↗

Expression of CD1d under the control of a MHC class Ia promoter skews the development of NKT cells, but not CD8+ T cells.

Although CD1d and MHC class Ia share similar overall structure, they have distinct levels and patterns of surface expression. While the expression of CD1d1 is known to be essential for the development of NKT cells, the contribution of CD1d1 to the development of CD8(+) T cells appears to be inconsequential. To investigate whether CD1d tissue distribution and expression levels confer differential capacity in selecting these two T cell subsets, we analyzed CD8 and NKT cell compartments in K(b)-CD1d-transgenic mice that lack endogenous MHC class Ia and CD1d, respectively. We found that MHC class Ia-like expression pattern and tissue distribution are not sufficient for CD1d to rescue the development of CD8(+) T cells, suggesting that unique structural features of CD1d preclude its active participation in selection of CD8(+) T cells. Conversely, cell type-specific CD1d surface density is important for the selection of NKT cells, as the NKT cell compartment was only partially rescued by the K(b)-CD1d transgene. We have previously demonstrated that increased CD1d expression on dendritic cells enhanced negative selection of NKT cells. In this study, we show that cell type-specific expression levels of CD1d establish a narrow window between positive and negative selection, suggesting that the distinct CD1d expression pattern may be selected evolutionarily to ensure optimal output of NKT cells.

Animals↗

Repeated alpha-galactosylceramide administration results in expansion of NK T cells and alleviates inflammatory dermatitis in MRL-lpr/lpr mice.

NK T (NKT) cells expressing the invariant Valpha14-Jalpha18 TCR alpha-chain recognize glycolipid Ags such as alpha-galactosylceramide (alpha-GalCer) presented by the MHC class I-like molecule CD1d. Upon activation by alpha-GalCer, invariant NKT cells secrete multiple cytokines and confer protection in certain immune-mediated disorders. Here we have investigated the role of NKT cells in the development of inflammatory dermatitis in MRL-lpr/lpr mice, which shares features with lupus in humans. Our results show that the numbers Sand functions of NKT (TCRbeta(+)CD1d/alpha-GalCer tetramer(+)) cells, particularly of the NK1.1(-) subset, are reduced in MRL-lpr/lpr mice compared with MRL-fas/fas and/or nonautoimmune C3H/Hej and BALB/c mice. Repeated treatments with alpha-GalCer result in the expansion of NKT cells and alleviate dermatitis in MRL-lpr/lpr mice. Our results indicate that NKT cell deficiency can be corrected by repeated alpha-GalCer treatment and that NKT cells may play a protective role in inflammatory dermatitis of lupus-prone mice.

Animals↗

A metallothionein-like gene htMT2 strongly expressed in internodes and nodes of Helianthus tuberosus and effects of metal ion treatment on its expression.

A cDNA sequence encoding a type-2 metallothionein (MT)-like protein, designated htMT2, was isolated from a Helianthus tuberosus L. tuber cDNA library. The isolated cDNA is 509 bp, coding a 7.8-kDa polypeptide. Two partial genomic fragments covering the open reading frame of htMT2 were cloned by PCR. The fragments htMTG-1 (986 bp) and htMTG-2 (982 bp) contain three exons and two introns. The N- and C-terminal domains of the predicted polypeptide have eight and seven cysteine residues, separated by a central cysteine-free spacer. Sequence alignment revealed that the predicted protein was homologous to type-2 MTs of plants. Southern blot analysis indicated that htMT2 is encoded by a small multi-gene family in the H. tuberosus genome. Northern blot analysis showed that htMT2 transcripts were predominantly expressed in internodes and nodes, but were low in leaves, leafstalks, tubers and young roots, and none was detected in roots. Treatment with Cu(2+) reduced the expression of htMT2 in internodes, nodes, leaves and leafstalks. In addition, the expression levels in internodes and nodes share an inverse relationship with the concentrations of Cu(2+). In internodes and nodes, treatment with Zn(2+) at 10 and 100 microM reduced the expression levels of htMT2, and 1000 microM Zn(2+)reduced it to the lowest level, but 500 microM Zn(2+) had little effect. The expressions of htMT2 in different tissues were not appreciably affected by heat shock. It is suggested that HtMT2 might be involved in the transport or availability of Cu(2+) and Zn(2+) to some apo-metal enzymes or apo-metal proteins.

Amino Acid Sequence↗

CD1d-expressing dendritic cells but not thymic epithelial cells can mediate negative selection of NKT cells.

Natural killer T (NKT) cells are a unique immunoregulatory T cell population that is positively selected by CD1d-expressing thymocytes. Previous studies have shown that NKT cells exhibit autoreactivity, which raises the question of whether they are subject to negative selection. Here, we report that the addition of agonist glycolipid alpha-galactosylceramide (alpha-GalCer) to a fetal thymic organ culture (FTOC) induces a dose-dependent disappearance of NKT cells, suggesting that NKT cells are susceptible to negative selection. Overexpression of CD1d in transgenic (Tg) mice results in reduced numbers of NKT cells, and the residual NKT cells in CD1d-Tg mice exhibit both an altered Vbeta usage and a reduced sensitivity to antigen. Furthermore, bone marrow (BM) chimeras between Tg and WT mice reveal that CD1d-expressing BM-derived dendritic cells, but not thymic epithelial cells, mediate the efficient negative selection of NKT cells. Thus, our data suggest that NKT cells developmentally undergo negative selection when engaged by high-avidity antigen or abundant self-antigen.

Animals↗

[CpG-ODN is a potential candidate adjuvant for human vaccines].

OBJECTIVE: To evaluate the adjuvanticity of CpG-ODN for human vaccines in animal models. METHODS: To find suitable animal models, the human CpG-ODN were examined for their in vitro immunostimulatory activities for murine and Rhesus monkey immune cells. Then by using recombinant HBsAg as a model antigen, the adjuvanticity of human CpG-ODN was evaluated in the animal models. RESULTS: Rhesus monkey B cells responded well to all the human CpG-ODN, similarly as that of human B cells. In contrast, only the human CpG-ODN with the CpG motif 5'GTCGTT 3' (CpG2006 etc) could induce murine splenocytes to secret IgM and IFN-gamma, while those with the CpG motif 5'GTCGTC 3' (CpGT7 etc) had less or no effects. The results suggested that Rhesus monkeys and mice could be used as animal models to evaluate the in vivo activities of different human CpG-ODN. Immunized with HBsAg combined with various human CpG-ODN, the mice elicited a stronger Th1 humoral immunity. Consistent with the in vitro findings, CpG-ODN with the CpG motif 5'GTCGTT 3' were more potent than those with the CpG motif 5'GTCGTC 3'. But of note, all the sequences had the same ability for modulation of Th1/Th2 immune response, with the ratio of IgG2a/IgG1 around 1. However, human CpG-ODN had less adjuvanticity for HBsAg in Rhesus monkeys; only CpGT7 increased the antibody titers by 2 times, while CpG2006 had no effect. CONCLUSION: The preliminary results derived from animal models showed that CpG-ODN was a potential candidate Th1 adjuvant for human vaccines.

Adjuvants, Immunologic↗

[Augmentation of the immunostimulatory effects of plasmid DNA by incorporation of human CpG-oligodeoxynucletide].

OBJECTIVE: To study whether the immunostimulatory activities of DNA vaccine could be enhanced by incorporation of human CpG-oligodeoxynucleotide (ODN) into its plasmid backbone. METHODS: Various copies of human CpG2006 sequence with immonostimulating activity for both human beings and mice were transfected into plasmid. Mouse spleen cells were cultured together with different kinds of plasmid DNA and then the amounts of IgM and interferon gamma (IFN-gamma) in the supernatant were examined by antibody sandwich ELISA. HBsAg plus plasmid DNA, as adjuvant, was injected into the shank muscles of 6 BALB/c mice in experimental group and recombinant HBsAg plus Al (OH)(2) was injected into 6 mice as controls. Four weeks later, the anti-HBsAg, IgG1 and IgG2a in their blood were examined. RESULTS: A minimum plasmid named pMini was constructed, containing only kanamycin-resistant gene and pUC18 replication origin. By incorporating different amounts of CpG2006 into pMini plasmid, two recombinant plasmids, pCpG11 and pCpG26, with 9 and 16 copies of CpG2006 respectively, were derived. With the increase of number of CpG2006 copies, the ability of recombinant plasmid DNA to induce the secretion of IgM by cultured murine splenocytes increased accordingly in sequence of pCpG26 > pCpG11 > pMini, and its ability to induce the secretion of IFN-gamma by cultured murine splenocytes decreased instead in sequence of pCpG26 < pCpG11 > pMini. After the mice were immunized with recombinant HBsAg plus pMini and pCpG1, the anti-HBs total antibodies and IgG1 isotype in their blood remained unchanged (P > 0.05), but pCpG26 increased the levels of anti-HBs total antibodies and IgG1 isotype by 3 times (P < 0.001) and 2 times (P < 0.02) respectively. The three kinds of plasmid DNA increased the level of specific IgG2a isotype by 5 approximately 10 times at similar degrees (P > 0.05). CONCLUSION: The immunostimulatory activities of plasmid DNA can be enhanced by incorporation of human CpG-ODN.

Adjuvants, Immunologic↗